Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines
BelgiumStudy on the Effects of AP1189 and Methotrexate for Patients with Early Rheumatoid Arthritis and Active Inflammation
BulgariaStudy of Vutrisiran for Patients with Transthyretin Amyloidosis and Heart Disease
AustriaStudy on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines
BulgariaStudy on the Effectiveness and Safety of Vibozilimod for Adults with Moderate to Severe Plaque Psoriasis
EstoniaStudy on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma Not Well Controlled
BulgariaStudy on Long-Term Safety of Depemokimab for Adults and Adolescents with Severe Eosinophilic Asthma
CzechiaStudy on the Effects of GSK1070806 Injection in Adults with Moderate to Severe Atopic Dermatitis
BulgariaStudy on Long-term Safety of TAK-881 (Human Normal Immunoglobulin, Hyaluronidase) for Patients with Primary Immunodeficiency Diseases
CzechiaStudy on the Effectiveness and Safety of ANB032, Betamethasone Dipropionate, and Hydrocortisone for Patients with Moderate to Severe Atopic Dermatitis
CzechiaStudy on the Effectiveness and Safety of Ocrelizumab for Patients with Progressive Multiple Sclerosis
CzechiaStudy on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Patients with Asthma
BulgariaThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
